Showing results (141-150 of 782) with videos related to

Sort By:
Pageof 79
The Lancet. HIV|April 23, 2017
Sources of racial disparities in HIV prevalence in men who have sex with men in Atlanta, GA, USA: a modelling studySteven M Goodreau, Eli S Rosenberg, Samuel M Jenness, et al.
The Lancet. HIV|April 16, 2017
Comparison of dynamic monitoring strategies based on CD4 cell counts in virally suppressed, HIV-positive individuals on combination antiretroviral therapy in high-income countries: a prospective, observational studyEllen C Caniglia, Lauren E Cain, Caroline A Sabin, et al.
The Lancet. HIV|April 19, 2017
Pitavastatin versus pravastatin in adults with HIV-1 infection and dyslipidaemia (INTREPID): 12 week and 52 week results of a phase 4, multicentre, randomised, double-blind, superiority trialJudith A Aberg, Craig A Sponseller, Douglas J Ward, et al.
The Lancet. HIV|March 7, 2017
Health-adjusted life expectancy in HIV-positive and HIV-negative men and women in British Columbia, Canada: a population-based observational cohort studyRobert S Hogg, Oghenowede Eyawo, Alexandra B Collins, et al.
The Lancet. HIV|April 15, 2019
Re-emergence of HIV related to injecting drug use despite a comprehensive harm reduction environment: a cross-sectional analysisAndrew McAuley, Norah E Palmateer, David J Goldberg, et al.
The Lancet. HIV|January 26, 2023
Adult HIV-1 incidence across 15 high-burden countries in sub-Saharan Africa from 2015 to 2019: a pooled analysis of nationally representative dataNora E Rosenberg, Bonnie E Shook-Sa, Mincen Liu, et al.
The Lancet. HIV|February 6, 2023
Pregnancy and neonatal safety outcomes of timing of initiation of daily oral tenofovir disoproxil fumarate and emtricitabine pre-exposure prophylaxis for HIV prevention (CAP016): an open-label, randomised, non-inferiority trialDhayendre Moodley, Carl Lombard, Vani Govender, et al.
The Lancet. HIV|March 1, 2025
Pharmacokinetics and safety of dolutegravir in children receiving rifampicin tuberculosis treatment in South Africa (ORCHID): a prospective cohort studyAnushka Naidoo, Hylke Waalewijn, Kogieleum Naidoo, et al.
The Lancet. HIV|October 30, 2024
Ending AIDS as a public health threat: the imperative for clear messaging on U=U, viral suppression, and zero riskEmi E Okamoto, Florence Riako Anam, Solange Batiste, et al.
The Lancet. HIV|October 30, 2024
Initiation and continued use of oral pre-exposure prophylaxis among pregnant and postpartum women in South Africa (PrEP-PP): a demonstration cohort studyDvora Leah Joseph Davey, Rufaro Mvududu, Nyiko Mashele, et al.
Pageof 79